Bank Julius Baer & Co’s MediciNova MNOV Stock Holding History

Bank Julius Baer & Co’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,027	Closed	-$39.9K	–	646
2024 Q3	$39.9K	Sell	16,027 -1,046	-6%	-$1.55K	﹤0.01%	476
2024 Q2	$27.4K	Sell	17,073 -1,927	-10%	-$2.7K	﹤0.01%	468
2024 Q1	$27.6K	Hold	19,000	–	–	﹤0.01%	497
2023 Q4	$28.5K	Buy	+19,000	New	+$34.3K	﹤0.01%	497
2023 Q3	–	Sell	-18,650	Closed	-$43K	–	551
2023 Q2	$43K	Sell	18,650 -350	-2%	-$771	﹤0.01%	502
2023 Q1	$41K	Hold	19,000	–	–	﹤0.01%	520
2022 Q4	$39K	Buy	19,000 +300	+2%	+$663	﹤0.01%	518
2022 Q3	$41K	Sell	18,700 -300	-2%	-$694	﹤0.01%	511
2022 Q2	$48K	Hold	19,000	–	–	﹤0.01%	525
2022 Q1	$51K	Hold	19,000	–	–	﹤0.01%	518
2021 Q4	$51K	Buy	+19,000	New	+$63.5K	﹤0.01%	656

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank Julius Baer & Co's MNOV Position: Q4 2024 in Review

Bank Julius Baer & Co sold out of MediciNova (MNOV) in Q4 2024, closing a stake of 16,027 shares — an estimated $39.9K sold.

Bank Julius Baer & Co first reported a position in MNOV in Q4 2021 and held it in 11 quarters. The position peaked at $51K in Q1 2022. 30 funds tracked by Wall St. Rank hold MNOV as of Q4 2024.

Bank Julius Baer & Co reported no remaining MediciNova position as of Q4 2024 after selling out during the quarter.
Bank Julius Baer & Co sold 16,027 MediciNova shares in Q4 2024, an estimated $39.9K.
Bank Julius Baer & Co first reported a position in MediciNova in Q4 2021 and held it in 11 quarters.
Bank Julius Baer & Co's MediciNova position peaked at $51K in Q1 2022.
30 funds tracked by Wall St. Rank held MediciNova as of Q4 2024.

Based on Bank Julius Baer & Co's 13F filing for Q4 2024, filed 7 Feb 2025.